Last reviewed · How we verify

NCT05038566

Dexterous Partial Hand Prosthesis Outcomes

Completed NA Results posted Last updated 17 January 2025
What this trial tests

NA trial testing Pointdexter in Amputation in 4 participants. Completed in 28 April 2022.

Timeline
15 July 2021
Primary endpoint
28 April 2022
28 April 2022

Quick facts

Lead sponsorLiberating Technologies, Inc.
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designcrossover
Maskingnone
Primary purposedevice feasibility
Enrollment4
Start date15 July 2021
Primary completion28 April 2022
Estimated completion28 April 2022
Sites2 locations across United States

Drugs / interventions tested

Conditions studied

Sponsor

Liberating Technologies, Inc.

Who can join

Eligibility, any sex, with Amputation or Amputation; Traumatic, Hand. Patients with the condition only — healthy volunteers not accepted.

Results — posted to ClinicalTrials.gov

Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.

Jebsen-Taylor Small Common Objects Functional Test Primary · 4 hours at a single site visit

During the in-lab portion of the study, subjects will be asked to complete the 'small common objects' subtask of the Jebsen-Taylor Hand Function Test, which assesses a broad range of unimanual hand functions required for ADLs. The primary quantitative measure of the Jebsen-Taylor task will be completion time of each subtask. The maximum time allotted for each task was 120 seconds, at which point the subject was told to stop the task and the time was reported as the maximum 120 seconds. This test will be used to evaluate the feasibility of the device design as compared with a baseline condition

Turning a Card Over
GroupValue95% CI
Comparator Baseline34.8± 20.5
Pointdexter26.1± 4.5
Small Common Objects
GroupValue95% CI
Comparator Baseline97.2± 32.2
Pointdexter62.1± 2.2
Stacking Checkers
GroupValue95% CI
Comparator Baseline37.5± 43.1
Pointdexter28± 21.8
Manipulating Cloth
GroupValue95% CI
Comparator Baseline5.4± 1.5
Pointdexter5.8± 1.7
Holding a Screw
GroupValue95% CI
Comparator Baseline24.1± 1.8
Pointdexter65.7± 34.7
9-Hole Out
GroupValue95% CI
Comparator Baseline11.4± 8.1
Pointdexter23.3± 19
9-Hole In
GroupValue95% CI
Comparator Baseline120± 0
Pointdexter63.8± 57.3
Removing Pen Cap
GroupValue95% CI
Comparator Baseline5.8± 2.3
Pointdexter7.1± 4.2

Sponsor's own description

Liberating Technologies, Inc. (LTI) has developed a dexterous prosthetic fingertip that will be fit onto an i-Digits™ partial hand prosthesis and allow for an additional fine grasp. The device will interface with research participants' existing prostheses and use the same control strategy that is used for their everyday use. Each participant's prosthesis will be restored to their original configuration by the end of their testing period.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Pointdexter

Trials testing the same drug.

Other recruiting trials for Amputation

Currently open trials in the same condition.

Other Liberating Technologies, Inc. trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05038566.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing